| |
r
|
p
|
|---|
|
Tensin2
|
|
Glut4
|
0.537
|
0.001*
|
|
IRS-1
|
0.335
|
0.043*
|
|
Ki-67
|
0.432
|
0.012*
|
|
CD31
|
0.435
|
0.011*
|
|
E-cadherin
|
0.289
|
0.102
|
|
N-cadherin
|
0.452
|
0.008*
|
|
Fibronectin
|
- 0.361
|
0.039*
|
|
Caspase3
|
- 0.083
|
0.644
|
|
pAkt (nuclei)
|
0.297
|
0.093
|
|
pAkt (cytoplasm)
|
- 0.029
|
0.872
|
|
pErk (nuclei)
|
0.182
|
0.319
|
|
pErk (cytoplasm)
|
0.229
|
0.200
|
|
Axl
|
|
Glut4
|
0.247
|
0.165
|
|
IRS-1
|
0.133
|
0.461
|
|
Ki-67
|
0.119
|
0.509
|
|
CD31
|
0.251
|
0.159
|
|
E-cadherin
|
0.072
|
0.690
|
|
N-cadherin
|
- 0.168
|
0.350
|
|
Fibronectin
|
- 0.345
|
0.049*
|
|
Caspase3
|
0.149
|
0.408
|
|
pAkt (nuclei)
|
0.058
|
0.746
|
|
pAkt (cytoplasm)
|
0.217
|
0.224
|
|
pErk (nuclei)
|
0.186
|
0.307
|
|
pErk (cytoplasm)
|
0.033
|
0.856
|
- The correlations were evaluated using the Pearson correlation test
- Glut4 and IRS1 are involved in glycolysis; Ki-67, proliferation marker; CD31, angiogenesis marker; E-cadherin, epithelial marker; N-cadherin and fibronectin, mesenchymal marker; Caspase 3, apoptosis marker. Patient number = 33, *p < 0.05
